Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03659136
Brief Title: The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

First Submitted : September 3, 2018
First Submitted that Met QC Criteria : September 3, 2018
First Posted : September 6, 2018

Last Update Submitted that Met QC Criteria : July 22, 2021
Last Update Posted : July 23, 2021